MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

FDA Announces Clinical Trials Initiative

FDA has unveiled the Human Subject Protection and Bioresearch Monitoring Initiative, which aims to modernize the regulation of clinical trials and bioresearch monitoring in the device, drug, veterninary products, food, and biologics industries. This is part of the agency's Critical Path Initiative to get important health technologies to market more efficiently. Conducting clinical trials properly and choosing the right clinical endpoints have never been more important to the success of a device company.

The new initiative underscores that and is something that must be paid attention to.

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish